Five Women Critical After C-Section Delivery At Jodhpur’s Umaid Hospital

While two of them have been put on ventilators, three others are undergoing treatment in the ICU. Specialists from the Gynaecology department are attending them.

Jodhpur: Five women who underwent a C-section delivery at the Umaid Hospital in Rajasthan’s Jodhpur deteriorated following heavy bleeding. While two of them have been put on ventilators, three others are undergoing treatment in the ICU.

Dr BS Jodha, principal of SN Medical College, said such situations arise due to complications in various cases. “A team of doctors is monitoring all the patients. It would be premature to pinpoint a specific cause now. Every precaution is being taken, and the drug department has been contacted,” he added.

Hospital superintendent Dr Mohan Makwana said specialists from the Gynaecology department are attending to the critically ill women.

Umaid Hospital typically handles 60 to 70 deliveries a day, of which about 30 are C-sections. However, in the last two days, the number of Caesarean operations has surged to 60.

Doctors explain that pregnant women showing even minor complications at rural health centres or private hospitals are being referred to Umaid Hospital, leading to a sudden increase in the patient inflow. There has been a rise in referral cases following similar incidents reported elsewhere in the state recently.

Earlier, the health of eight women had deteriorated after C-section deliveries at Paota district hospital, and two of them had to be referred to AIIMS.

However, subsequent investigations showed normal infection reports for all medicines and equipment, and all patients have since recovered and been discharged. The recent incident from the Umaid Hospital has put the health department on high alert.

 

Related Posts

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

The Team Meticulously averted the Risk of Thrombosis, Husband was Donor Delhi/NCR : Doctors at Yashoda Medicity have successfully performed a high-risk kidney transplant in a 28-year-old woman with Antiphospholipid…

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta, a UK-based clinical stage biotech, is differentiated clinical-stage oncology specialist, increasingly defined by continuing progress with its second-generation pre|CISION tumour-activated Peptide Drug Conjugate (PDC) platform. The lead Gen Two…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Puresta launches EVERQ, AI-powered skin-health platform

Puresta launches EVERQ, AI-powered skin-health platform

Stem cell therapy for autism only in approved clinical trials: Centre

Stem cell therapy for autism only in approved clinical trials: Centre